Clinical Trial

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, blinded, peer-controlled study. There will be 3 treatment groups, screened subjects were randomized in a 1:1:1 ratio to receive three batches of the DTcP trial vaccine, and completed the primary immunization according to the procedure of one dose each at 2, 4, and 6 months of age.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-26; most recent amendment 2025-08-14.
Status change: Recruiting → Active, Not Recruiting 2025-08-14
Status change: Not Yet Recruiting → Recruiting 2025-03-28
Trial Details
NCT Number NCT06857370
Lead Sponsor CanSino Biologics Inc.
Conditions Diphtheria, Tetanus and Acellular Pertussis
Enrollment 780 participants
Start Date 2025-03-23
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-15